Literature DB >> 24281013

Clinical and histological features of different types of Budd-Chiari syndrome: a comparison of 4 cases.

Naoshi Nishida1, Shinichi Iwamura, Hiroshi Ida, Satoshi Hagiwara, Yoshinori Kagioka, Yasunori Minami, Yoji Maetani, Kyo Itoh, Masatoshi Kudo.   

Abstract

Budd-Chiari syndrome (BCS) is a rare condition characterized by hepatic venous outflow obstruction. In this report, we present 4 cases of BCS with complete and incomplete obstruction of the inferior vena cava (IVC) and hepatic vein (HV). Each case showed different and unique features of liver damage, which were attributed to the site and degree of obstruction. Interestingly, improved liver functions such as increased serum albumin levels, decreased hyaluronic acid levels and a normal indocyanine green clearance test were evident within 1 month of the balloon angioplasty. Pericellular fibrosis and hypervascular regenerative nodules were also reversible after obstruction removal. Therefore, it is very important to manage this rare disease before it progresses to liver cirrhosis.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24281013     DOI: 10.1159/000355237

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  3 in total

1.  Budd-Chiari Syndrome: an unnoticed diagnosis.

Authors:  Camila Kruschewsky Falcão; Gustavo C Freitas Fagundes; Gustavo Checolli Lamos; Aloisio Felipe-Silva; Silvana Maria Lovisolo; João Augusto Martines; Fernando Peixoto Ferraz de Campos
Journal:  Autops Case Rep       Date:  2015-06-30

2.  Imbalance of pro- vs. anti-coagulation factors in Chinese patients with Budd-Chiari syndrome and non-cirrhotic portal vein thrombosis.

Authors:  Hui Chen; Lei Liu; Xingshun Qi; Chuangye He; Zhanxin Yin; Feifei Wu; Daiming Fan; Guohong Han
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Histopathology of inferior vena cava obstruction in Budd-Chiari syndrome by clamp biopsy.

Authors:  Yonghua Bi; Xiaoyan Zhu; Mengfei Yi; Xinwei Han; Jianzhuang Ren
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.